0.8500
+0.1570
+(22.66%)
At close: January 15 at 4:00:01 PM EST
0.8030
-0.05
(-5.53%)
After hours: 7:59:59 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
502.0000
644.0000
787.0000
522.0000
661.0000
Cost of Revenue
518.0000
583.0000
463.0000
298.0000
388.0000
Gross Profit
-16.0000
61.0000
324.0000
224.0000
273.0000
Operating Expense
12,986.0000
12,330.0000
15,083.0000
18,366.0000
14,659.0000
Operating Income
-13,002.0000
-12,269.0000
-14,759.0000
-18,142.0000
-14,386.0000
Net Non Operating Interest Income Expense
-14.0000
257.0000
-834.0000
--
--
Other Income Expense
4,157.0000
3,162.0000
1,521.0000
10.0000
256.0000
Pretax Income
-8,859.0000
-8,850.0000
-14,072.0000
-18,132.0000
-14,130.0000
Net Income Common Stockholders
-8,859.0000
-8,850.0000
-14,072.0000
-18,132.0000
-14,130.0000
Diluted NI Available to Com Stockholders
-8,859.0000
-8,850.0000
-14,072.0000
-18,132.0000
-14,130.0000
Basic EPS
-4.27
-14.56
-52.13
-369.00
-590.00
Diluted EPS
-4.27
-14.56
-52.13
-369.00
-590.00
Basic Average Shares
1,950.2160
607.8900
269.9290
49.1350
23.9550
Diluted Average Shares
1,950.2160
607.8900
269.9290
49.1350
23.9550
Total Operating Income as Reported
-13,002.0000
-12,428.0000
-15,516.0000
-18,142.0000
-14,386.0000
Total Expenses
13,504.0000
12,913.0000
15,546.0000
18,664.0000
15,047.0000
Net Income from Continuing & Discontinued Operation
-8,859.0000
-8,850.0000
-14,072.0000
-18,132.0000
-14,130.0000
Normalized Income
-12,763.0000
-11,932.0000
-15,586.0000
-18,142.0000
-14,323.0000
Interest Expense
--
--
834.0000
--
--
Net Interest Income
-14.0000
257.0000
-834.0000
--
--
EBIT
-13,002.0000
-12,269.0000
-14,759.0000
-18,132.0000
-14,386.0000
EBITDA
-12,933.0000
-12,107.0000
-14,504.0000
-17,820.0000
-13,904.0000
Reconciled Cost of Revenue
478.0000
538.0000
389.0000
186.0000
269.0000
Reconciled Depreciation
69.0000
162.0000
255.0000
312.0000
482.0000
Net Income from Continuing Operation Net Minority Interest
-8,859.0000
-8,850.0000
-14,072.0000
-18,132.0000
-14,130.0000
Total Unusual Items Excluding Goodwill
3,904.0000
3,082.0000
1,514.0000
10.0000
193.0000
Total Unusual Items
3,904.0000
3,082.0000
1,514.0000
10.0000
193.0000
Normalized EBITDA
-16,837.0000
-15,189.0000
-16,018.0000
-17,830.0000
-14,097.0000
12/31/2020 - 6/27/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MASS 908 Devices Inc.
2.9100
+46.97%
IINN Inspira Technologies Oxy B.H.N. Ltd.
1.0600
+2.91%
AIMD Ainos, Inc.
0.6683
-4.53%
VTAK Catheter Precision, Inc.
0.4460
-5.67%
NAOV NanoVibronix, Inc.
0.5700
+19.72%
TIVC Tivic Health Systems, Inc.
0.2665
+0.64%
BDMD Baird Medical Investment Holdings Limited
6.62
-14.36%
ADGM Adagio Medical Holdings, Inc.
0.8432
-4.45%
ALUR Allurion Technologies Inc.
3.5700
+13.69%
RPID Rapid Micro Biosystems, Inc.
1.2650
+16.06%